Titlebook: Cancer Chemotherapy: Concepts, Clinical Investigations and Therapeutic Advances; F. M. Muggia Book 1989 Kluwer Academic Publishers 1989 ca

Innovative

虛假

K. P. Wong,B. Y. Khoo,T. M. C. Tan,K. H. SitThe ability to kill local tumor within the esophagus is less in doubt with systemic treatment of chemotherapy than the impact on that therapy on the overall survival of patients with squamous cell carcinoma of the esophagus (SCCE).

Haphazard

The role of chemotherapy in the treatment of squamous cell tumors of the esophagusThe ability to kill local tumor within the esophagus is less in doubt with systemic treatment of chemotherapy than the impact on that therapy on the overall survival of patients with squamous cell carcinoma of the esophagus (SCCE).

A精確的

Laboratory aspects of multidrug resistances chapter to emphasize the genetic nature of the MDR phenomenon and to review the studies that bear upon this. At the same time, we speculate on the implications of this phenotype for clinical cancer chemotherapy.

exclusice

直言不諱

https://doi.org/10.1007/978-3-662-08964-4ular receptors or circulating blood components such as the Fc receptor and complement. Fragmentation of the molecule can simplify its structure without damaging the antigenic binding sites or carrier function.

Flawless

一小塊

Alkylating agents: Mechanisms and modulationanism(s) by which alkylating agents kill human tumor cells has not been completely characterized and is therefore not fully understood. The lack of understanding arises in part from the vast diversity of agents, both mono-functional and bifunctional, that have antitumor activity and also from the nu

無彈性

Reduced folates and fluoropyrimidine antitumor efficacyliative agents in the treatment of certain malignancies in adults [1–3] and have been employed to a limited extent in children [4, 5]. They constitute some of the most extensively studied anticancer agents. However, the relevant mechanism(s) of action in human cancers in vivo achieved at pharmacolog

Extemporize